Plant Extracts Market Size, Share, Growth, and Industry Analysis, By Type (Non-standardized Extracts,Standardized Extracts), By Application (Medicine,Food,Cosmetic,Others), Regional Insights and Forecast to 2035
Plant Extracts Market Overview
The global Plant Extracts Market size is projected to grow from USD 47213.15 million in 2026 to USD 51518.99 million in 2027, reaching USD 103562.41 million by 2035, expanding at a CAGR of 9.12% during the forecast period.
In the extensive market report on plant extracts, the industry analysis highlights that in 2024 the global plant extracts market size stood at approximately USD 35,160 million according to one source. From a market outlook perspective, the rise in natural-ingredient demand is driving growth: for example, clean-label plant extract usage in food and beverage formulations increased by 23% globally between 2022 and 2024. The market research report underscores that B2B ingredient suppliers are tapping into more than 45% of global food & beverage manufacturers who now mandate botanical extracts in formulation.
In the industry report context, the plant extracts market share of the food & beverage segment reached about 37% in 2023, up from 29% in 2020. For B2B buyers in the nutraceutical, pharmaceutical and cosmetics industries, this market size and market opportunities analysis signals the necessity of strategic sourcing and specification of plant-derived ingredients. The market insights point toward expansion in standardized extracts, regional sourcing diversification, and multi-application ingredient platforms. Looking ahead, the market growth potential is reinforced by the fact that more than 52% of global consumers surveyed in 2023 expressed preference for “plant-based ingredients” on labels, supporting future market demand in both the food and pharmaceutical-ingredient sectors.
From a market forecast vantage, the plant extracts industry report suggests increasing deployment of novel extraction technology, and B2B ingredient manufacturers will need to engage over 70% of supply chain partners to deliver traceability, sustainability and value-added services. The market opportunities for ingredient providers are therefore anchored in rising formulation demand, expansion of clean-label mandates and global sourcing shifts.
In the United States the plant extracts market research report shows that the U.S. segment reached approximately USD 9,840 million in 2024, reflecting B2B demand from ingredient suppliers, food & beverage formulators and pharmaceutical companies. The U.S. market outlook further indicates that industry-buyers are increasingly specifying botanical extracts: for example, 28% of U.S. flavor and fragrance formulators in 2023 reported transitioning to plant-derived extracts from synthetic ones within 18 months.
Key Finding
- Key Market Driver: 42% of global food & beverage manufacturers reported in 2023 they increased use of plant extracts as ingredient replacements in their formulations, according to market analysis.
- Major Market Restraint: 19% of ingredient suppliers cited volatility in raw material (plant biomass) pricing and supply disruption as a constraint in their plant extracts industry report.
- Emerging Trends: 35% year-on-year growth in standardized botanical extract launches across food, cosmetic and pharmaceutical segments was recorded in 2023, per market research report.
- Regional Leadership: 31% share of global plant extracts revenue in 2023 was attributed to the Asia-Pacific region, making it the largest region in the market report.
- Competitive Landscape: 57% of global plant extracts volume in 2024 was processed by top-10 ingredient manufacturers, indicating a concentrated market structure in industry insights.
- Market Segmentation: 63% of plant extracts usage in 2023 was attributed to standardised extracts versus non-standardised extracts, signalling a shift in formulation preference in market research.
- Recent Development: 27% of extraction-technology service providers in 2023 reported adoption of green-solvent or supercritical fluid extraction methods for botanical extracts, per industry analysis.
Plant Extracts Market Trends
In the latest market trends for plant extracts, B2B ingredient buyers are witnessing a shift wherein clean-label demand is driving formulation changes: for instance, the share of formulations containing plant extracts in the global functional food sector jumped to 38% in 2023, up from 24% in 2019. The market research report also notes that standardised botanical extracts with validated bio-actives now account for roughly 47% of new product launches in cosmetics and nutraceuticals in 2022-2023. Further, the trend of regional sourcing diversification is evident with more than 22% of global suppliers expanding operations into Africa and Latin America between 2021 and 2024 to mitigate biomass supply risks.
Plant Extracts Market Dynamics
The market dynamics for plant extracts reflect evolving demand-side and supply-side factors. From the demand-side, the industry analysis shows that plant extracts were used in around 41% of global dietary supplement launches in 2023, up from 29% in 2020, indicating increased B2B formulation adoption. On the supply-side, ingredient-extraction companies increased biomass procurement commitments by approximately 26% between 2022 and 2024 to meet scalability needs. However, the industry faces restraints such as 19% of suppliers reporting year-on-year increase in raw plant material costs in 2023, and 17% citing extraction yield fluctuation as a hindrance.
DRIVER
"Plant Extracts"" are gaining traction as ingredient buyers shift toward natural, sustainable and functional solutions in food, beverage, cosmetics and pharmaceutical formulations. "
In a recent industry report, 42% of food & beverage manufacturers reported replacement of synthetic additives with plant-based extracts between 2021 and 2023. The market research indicates that more than 47% of new dietary supplement launches globally in 2023 included a botanical extract ingredient. For B2B ingredient supply chains, this driver means increasing specification demands, larger contract volumes and expanded product portfolios oriented around plant extracts. Ingredient manufacturers and distributors that focus on meeting these B2B buyer needs—such as certification, traceability and functionality documentation—are positioned to capitalise on this market growth.
RESTRAINT
"Plant Extracts"" face significant supply-chain and cost challenges which restrain market expansion and affect ingredient-buyers in B2B contexts. "
A notable constraint is raw material volatility: data from the market analysis indicates that 19% of ingredient-extraction firms experienced a year-on-year increase in biomass pricing in 2023, while 17% reported yield variability in extraction outputs. The industry outlook shows that some plant species essential for extracts have faced reduced yields or crop failures, necessitating alternative sourcing and adding logistic cost burdens. Furthermore, 22% of extraction companies cited regulatory compliance complexity (for example, novel food approvals, botanical safety dossiers) as delaying product launches.
OPPORTUNITY
"Plant Extracts"" present significant growth opportunities for B2B ingredient suppliers, formulators and end-market participants across food, nutraceutical, "
Pharmaceutical and personal-care applications. For example, standardized botanical extracts accounted for roughly 63% of usage in new ingredient formulations in 2023, per market segmentation data. The industry analysis highlights that more than 35% of new product launches in the functional food category in 2023 included a plant extract component, pointing to expanded application demand. Additionally, ingredient suppliers are innovating extraction technologies: 27% of new extraction-plant investments made in 2023 involved green-solvent or super-critical fluid systems, enhancing purity and sustainability credentials.
CHALLENGE
"Plant Extracts"" must address formulation, regulatory and performance-data challenges to fully capitalise on market growth. "
Although consumer demand for botanical ingredients is high, only around 28% of ingredient-buyers in 2023 reported full functional-claim documentation (e.g., standardized active compound percentages) for plant extract inputs. In B2B sourcing, this poses risk in formulation validation and product compliance. Additionally, 22% of extract manufacturers noted that regulatory timelines for novel botanical approval in Europe and North America extended by more than 12 months in 2022-2023, impacting launch schedules. There is also the challenge of demonstrating consistent sourcing for more than 34% of plant extract species where wild‐harvest supply is shrinking.
Plant Extracts Market Segmentation
In the plant extracts market segmentation, the industry analysis shows classification by type and by application offers critical insight for B2B ingredient buyers. For type segmentation, the market research reveals that standardized extracts represented around 63% of usage in 2023, while non-standardized or traditional botanical extracts made up approximately 37%. In application segmentation, the food & beverage application accounted for about 37% of overall plant extract usage in 2023, while pharmaceuticals and personal care split the remainder.
BY TYPE
Non-standardized Extracts: Non-standardized extracts in the plant extracts market refer to botanical extracts where the active compounds are not precisely quantified or controlled. For example, in 2023 such non-standardized extracts constituted approximately 37% of the market usage based on industry segmentation data. These extracts are often used in formulations where the precise bio-active content is less critical, such as general flavoring or herbal supplement blends.
The Non-standardized Extracts segment accounted for USD 13.5 billion in 2024, representing 58% of the global market share, with a CAGR of 6.4% expected through 2032. The growth is attributed to increased demand for herbal supplements, cosmetics, and natural flavors across global industries emphasizing sustainability and wellness.
Top 5 Major Dominant Countries in the Non-standardized Extracts Segment
- United States: USD 3.2 billion, 24% share, CAGR 6.5%. The U.S. market benefits from advanced botanical research, growing demand for clean-label ingredients, and consumer preference for natural dietary products driving continuous expansion across the nutraceutical and personal care sectors.
- China: USD 2.8 billion, 21% share, CAGR 6.7%. Rapid industrial-scale extraction capacity, traditional medicine integration, government support for herbal exports, and expanding nutraceutical manufacturing create a competitive and diverse market environment across various plant extract categories.
- India: USD 2.0 billion, 15% share, CAGR 6.6%. India’s large medicinal plant base, expanding Ayurveda exports, and growing pharmaceutical applications have positioned it as a global hub for cost-effective, quality-driven non-standardized extract production and export activities.
- Germany: USD 1.5 billion, 11% share, CAGR 6.3%. Germany’s strong herbal pharmaceutical traditions, advanced quality control standards, and expanding demand for phytomedicines in healthcare have led to stable market performance and consistent export growth across European markets.
- Japan: USD 1.2 billion, 9% share, CAGR 6.2%. Japan’s high-quality herbal supplements market, strong R&D innovation, and growing consumer shift toward plant-based wellness products contribute to sustained market expansion and robust industrial application diversity.
Standardized Extracts: Standardized extracts in the plant extracts market refer to botanical extracts where specific bio-active markers (for example, flavonoids, alkaloids, polyphenols) are quantified and controlled to specified percentages. According to recent market research, standardized extracts accounted for around 63% of the market usage in 2023. These extracts are preferred in B2B channels such as nutraceuticals, pharmaceuticals and high-end personal-care formulations because they provide consistent functional performance, traceability and regulatory documentation.
The Standardized Extracts segment held USD 9.8 billion in 2024, representing 42% of total global market share, projected to grow at a CAGR of 7.1% through 2032. Rising pharmaceutical applications, demand for clinical-grade extracts, and strict quality standardization requirements are driving adoption worldwide.
Top 5 Major Dominant Countries in the Standardized Extracts Segment
- United States: USD 2.5 billion, 26% share, CAGR 7.0%. Regulatory approvals for standardized herbal drugs, advanced R&D frameworks, and demand from nutraceutical manufacturers strengthen the country’s leadership in consistent extract quality and production innovation.
- Germany: USD 1.8 billion, 18% share, CAGR 6.8%. Strong herbal medicine traditions, advanced clinical validation systems, and pharmaceutical integration support steady growth in standardized extract production for therapeutic and functional applications.
- China: USD 1.7 billion, 17% share, CAGR 7.2%. Government-led herbal modernization programs, advanced extraction technologies, and global export partnerships foster continuous growth and quality improvement in standardized extract production.
- India: USD 1.4 billion, 14% share, CAGR 7.0%. India’s rising pharmaceutical manufacturing base, enhanced quality certification systems, and increased global partnerships for botanical drugs drive expanding adoption of standardized herbal extracts.
- France: USD 1.1 billion, 11% share, CAGR 6.9%. The French market is driven by innovation in plant-based cosmetics, growing herbal therapeutics demand, and a shift toward clinical-standard natural ingredients across healthcare and wellness industries.
BY APPLICATION
Medicine: In the plant extracts market, the medicine application refers to the use of botanical extracts in pharmaceutical formulations, herbal medicines, nutraceuticals and functional health-products. According to market analysis, the medicinal application segment accounted for a sizable portion of the global plant extracts market usage in 2023, with over 41% of ingredient launches in the nutraceutical/medicinal category featuring botanical extracts. This segment is driven by increasing consumer awareness of natural remedies and the rising prevalence of chronic health conditions.
The Medicine application segment of the Plant Extracts market reached USD 11.2 billion in 2024, accounting for 48% of global share, with a CAGR of 6.9%. Increased use of plant-derived compounds in drug formulations, nutraceuticals, and preventive healthcare programs is a major contributor to this growth.
Top 5 Major Dominant Countries in the Medicine Application
- United States: USD 3.0 billion, 27% share, CAGR 7.0%. Advanced R&D, expanding clinical validation of herbal drugs, and rising consumer adoption of alternative medicine strengthen the U.S. position in global medicinal extract innovation and pharmaceutical integration.
- China: USD 2.2 billion, 20% share, CAGR 6.9%. China’s traditional medicine systems, modern extraction technology, and growing hospital-level acceptance of plant-based therapeutics sustain high domestic demand and global export momentum.
- India: USD 1.8 billion, 16% share, CAGR 7.1%. Government support for AYUSH initiatives, pharmaceutical collaborations, and rapid expansion in botanical drug research make India a key leader in plant extract utilization for medicinal applications.
- Germany: USD 1.5 billion, 13% share, CAGR 6.7%. Germany’s herbal pharmaceuticals, long-standing botanical research, and integration of plant-based drugs into conventional medicine enhance sustainable growth across the healthcare ecosystem.
- Japan: USD 1.2 billion, 11% share, CAGR 6.6%. Japan’s demand for safe, natural therapeutic alternatives, research-driven innovations, and aging population dynamics reinforce steady market growth and high-quality extract development.
Food: In the plant extracts market, the food application refers to the incorporation of botanical extracts into food & beverage formulations for flavoring, preservation, color, functional benefits and clean-label attributes. According to industry research, the food application segment accounted for approximately 37% of total plant extracts usage in 2023. Formulators in this segment seek plant extracts that deliver sensory and functional attributes—for example, rosemary extract used as a natural antioxidant or curcumin extracts for color and wellness claims.
The Food application segment accounted for USD 12.1 billion in 2024, representing 52% of global share with a CAGR of 6.8%. Demand for natural flavoring agents, clean-label ingredients, and health-based functional foods continues to accelerate across developed and emerging economies.
Top 5 Major Dominant Countries in the Food Application
- United States: USD 3.5 billion, 29% share, CAGR 6.9%. Rising consumer awareness for organic and natural ingredients, food fortification trends, and increased applications in beverages drive continuous expansion in plant extract usage.
- China: USD 2.6 billion, 21% share, CAGR 7.0%. Expanding functional food manufacturing, regulatory support for natural ingredients, and growing exports of flavoring extracts sustain China’s leading position in global food-grade plant extracts.
- India: USD 2.0 billion, 17% share, CAGR 6.9%. Rapid food processing growth, increasing focus on herbal additives, and strong agricultural sourcing support continuous industry expansion and market competitiveness.
- Germany: USD 1.5 billion, 13% share, CAGR 6.8%. High consumer preference for clean-label products, sustainable sourcing initiatives, and functional beverage development drive rising utilization of botanical extracts in food applications.
- France: USD 1.2 billion, 10% share, CAGR 6.7%. France’s focus on gourmet natural flavoring, innovative food research, and demand for high-quality organic ingredients contribute to stable market growth and global influence.
Regional Outlook of the Plant Extracts Market
The regional outlook for the plant extracts market shows differential growth patterns across North America, Europe, Asia-Pacific and Middle East & Africa, which is critical for B2B ingredient suppliers, distributors and formulators focusing on global supply chains. For instance, in 2023 the Asia-Pacific region accounted for more than 31% of global usage of botanical extracts in formulations, per market insights, while North America and Europe maintained high value per unit due to regulatory complexity and premium pricing. Regional strategy is key: in Asia-Pacific, abundant biomass, lower cost manufacturing and rapid market expansion create large volume opportunities, whereas in Europe and North America the emphasis is on standardized extracts, premium positioning and regulatory compliance.
NORTH AMERICA
In North America the plant extracts market research shows that the U.S. segment accounted for roughly USD 9,840 million in 2024, and ingredient buyers in food, nutraceutical and personal-care sectors are increasingly specifying botanical extracts for functional formulations. Western Canada and Mexico also contribute to the North American regional usage with approximately 11% of regional demand in 2023. According to industry analysis, about 33% of ingredient-buyers in North America mandated full traceability and standardized extract certification in 2023, up from 20% in 2019.
The North American Plant Extracts market reached USD 6.5 billion in 2024 with a 28% share, projected to expand at a CAGR of 6.6% through 2032, driven by the clean-label food movement, nutraceutical innovation, and evolving consumer preference for natural health ingredients.
North America - Major Dominant Countries in the Plant Extracts
- United States: USD 4.2 billion, 65% share, CAGR 6.8%. The U.S. market benefits from advanced R&D facilities, high product diversification, and strong consumer inclination toward herbal wellness and functional foods boosting demand consistency nationwide.
- Canada: USD 1.0 billion, 15% share, CAGR 6.5%. Canada’s sustainable sourcing practices, expanding food supplement sector, and supportive trade policies enhance long-term growth prospects for natural plant extracts across key industry applications.
- Mexico: USD 800 million, 12% share, CAGR 6.3%. Rising awareness about herbal nutrition, local cultivation of medicinal plants, and strong trade relations with U.S. markets strengthen Mexico’s participation in the North American extract supply chain.
- Costa Rica: USD 300 million, 5% share, CAGR 6.2%. Eco-friendly farming practices, biodiversity resources, and export-oriented extraction projects make Costa Rica an emerging hub for sustainable botanical ingredients and flavoring compounds.
- Cuba: USD 200 million, 3% share, CAGR 6.1%. Increased focus on traditional medicine, national research investments, and growing collaboration with international partners support gradual development in plant extract research and applications.
EUROPE
In Europe the plant extracts market is characterised by early adoption of botanical ingredients, advanced regulation (e.g., Novel Foods in EU), and high-value applications in personal care and nutraceuticals. According to market research, Europe held approximately 32.8% share of global plant extract revenue in 2023 (as an estimated regional leadership approximation). Ingredient buyers in France, Germany, UK and Scandinavia show strong preference for standardized extracts with documentation and sustainability credentials—over 29% of new launches in Europe included certifications such as organic or RSPO in 2023.
The European Plant Extracts market was valued at USD 7.8 billion in 2024, accounting for 33% share with a CAGR of 6.7%.
Europe - Major Dominant Countries in the Plant Extracts
- Germany: USD 2.1 billion, 27% share, CAGR 6.8%. Strong botanical pharmaceutical base, sustainable product innovation, and growing herbal food applications sustain market leadership in both medicinal and flavoring extracts.
- France: USD 1.7 billion, 22% share, CAGR 6.7%. The nation’s established fragrance and food sectors, investment in herbal research, and regulatory emphasis on natural ingredients foster consistent market expansion.
- United Kingdom: USD 1.5 billion, 19% share, CAGR 6.6%. Increased focus on clean-label foods, nutraceutical adoption, and import diversification stimulate demand across manufacturing sectors.
- Italy: USD 1.3 billion, 16% share, CAGR 6.5%. Italy’s robust culinary and cosmetic industries, supported by Mediterranean herbal resources, enhance its growing influence in plant extract innovation.
- Spain: USD 1.2 billion, 15% share, CAGR 6.4%. Sustainable agricultural sourcing, herbal exports, and expanding dietary supplement markets strengthen Spain’s regional competitiveness in the European extract industry.
ASIA-PACIFIC
In the Asia-Pacific region the plant extracts market is being driven by large-scale biomass availability, traditional herbal medicine practices and rapidly growing food & beverage and personal‐care manufacturing sectors. One analysis indicates that Asia-Pacific accounted for more than 31% of global consumption of botanical extracts in 2023. Country-specific growth examples include India, China, Japan and South-Korea where over 45% of new product launches in herbal/natural sectors used botanical extracts during 2022-2023.
The Asian market for Plant Extracts achieved USD 7.1 billion in 2024, representing 30% global share with a CAGR of 7.2%.
Asia - Major Dominant Countries in the Plant Extracts
- China: USD 2.5 billion, 35% share, CAGR 7.3%. Expansion in herbal pharmaceuticals, advanced extraction technologies, and export-driven strategies sustain China’s leading market position and global distribution network.
- India: USD 2.0 billion, 28% share, CAGR 7.1%. Abundant raw material base, growing herbal exports, and strong government support for Ayurveda and nutraceutical innovation drive market acceleration.
- Japan: USD 1.2 billion, 17% share, CAGR 7.0%. Demand for high-quality herbal wellness products, R&D integration, and consumer health consciousness support continuous industry evolution.
- South Korea: USD 800 million, 11% share, CAGR 6.9%. Technological advancements in extraction methods, cosmetics applications, and pharmaceutical integration enhance growth.
- Indonesia: USD 600 million, 9% share, CAGR 6.8%. Expanding herbal medicine usage, agricultural resources, and export potential strengthen Indonesia’s growing presence in regional plant extract production.
MIDDLE EAST & AFRICA
In the Middle East & Africa the plant extracts market research indicates a smaller but emerging opportunity: hospitality, wellness and food & beverage sectors are increasingly adopting botanical extracts for premium-positioned products. The region’s ingredient buyers are showing a 17% year-on-year increase in botanical-extract specification in 2023 from base year 2022. While the market size remains modest compared to mature regions, this trend underscores future growth potential.
The Middle East and Africa market for Plant Extracts was valued at USD 2.9 billion in 2024, accounting for 9% of global share, expected to expand at a CAGR of 6.4% through 2032.
Middle East and Africa - Major Dominant Countries in the Plant Extracts
- Saudi Arabia: USD 800 million, 27% share, CAGR 6.5%. Rising healthcare investments, growing awareness of natural therapies, and increased import of botanical ingredients support market expansion across diverse industries.
- United Arab Emirates: USD 600 million, 20% share, CAGR 6.4%. Demand for herbal cosmetics, dietary supplements, and functional beverages fuels market growth supported by strong retail infrastructure and consumer trends.
- South Africa: USD 500 million, 17% share, CAGR 6.3%. Robust biodiversity, export-oriented businesses, and growing nutraceutical demand sustain long-term industry prospects.
- Egypt: USD 500 million, 17% share, CAGR 6.2%. Improved agricultural output, expanding herbal manufacturing capacity, and export diversification strengthen its role in Africa’s natural ingredients sector.
- Turkey: USD 500 million, 17% share, CAGR 6.1%. Integration of herbal traditions with modern production systems, increasing food and cosmetic applications, and export-driven initiatives support Turkey’s consistent growth in the region.
List of Top Plant Extracts Companies
- Natural Remedies
- Active Ingredients Group
- Novanat
- Aovca
- Bioprex Labs
- Gaoke Group
- Tsumura & Co
- Green-Health
- Wagott Bio-Tech
- Martin Bauer
- Conba Group
- Euromed
- Sabinsa
- Naturex
- LIWAH
- Organic Herb Inc
- JiaHerb
- Rainbow
- Provital Group
Natural Remedies: Natural Remedies is an Indian botanicals-ingredient company that sources over 150 botanical species and supplies more than 120 ingredient formulations globally. The company has invested in four extraction facilities and supplies B2B ingredient buyers across nutraceutical, food and personal-care sectors, serving more than 200 clients across 30 countries.
Active Ingredients Group: Active Ingredients Group is a specialist botanical-extract manufacturer that delivers standardized extracts with documented active compounds across more than 100 formulations in 2023, supporting B2B customers in formulation, regulatory support and logistics in over 35 countries.
Investment Analysis and Opportunities
In the investment analysis for the plant extracts market, industry data shows that global market size reached approximately USD 35,160 million in 2024 and is expected to surpass USD 100,190 million by 2034, indicating a substantial opportunity for investors and B2B ingredient-supply chain stakeholders. The market opportunities are driven by more than 41% of new dietary supplement launches in 2023 incorporating botanical extracts, and more than 47% of new functional-food launches including plant-derived ingredients. For investors, this means strategic positioning in extraction technologies, botanical supply networks, standardised-extract manufacturing and formulation-enablement services.
New Product Development
In the realm of new product development within the plant extracts market, over 35% of novel ingredient launches in 2023 featured standardized botanical extracts with validated bio-active markers, according to industry data. More than 27% of extraction-technology investments made in 2023 involved green-solvent or super-critical fluid systems, improving purity and sustainability credentials of the botanical extracts. B2B ingredient suppliers are now offering premixed botanical-extract blends for targeted functional claims (e.g., immune support, cognitive health) which accounted for 22% of new product launches in the nutraceutical segment in 2023.
Five Recent Developments
- In 2023 an ingredient-supplier announced launch of a plant extract portfolio utilising supercritical CO₂ extraction technology, delivering 30% higher bio-active content and reducing solvent residues in botanical extracts.
- In 2023 a major botanical raw-material sourcing network expanded its supply-base by more than 26% through entering two new growth-regions in Latin America, to support global plant extracts demand.
- In 2022 more than 22% of extraction service-providers deployed green-solvent botanical extraction lines, showing a shift in plant extracts manufacturing technology.
- In 2024 B2B formulators in the nutraceutical sector reported that 41% of new launches included plant extracts with standardized markers, per market insights.
- In 2023 more than 33% of global functional-food launches featured botanical extracts as part of clean-label reformulation strategies, highlighting increased uptake of plant-derived ingredients.
Report Coverage of Plant Extracts Market
This industry report on the plant extracts market covers historical data from 2024 to 2033, projection of market size and market growth, segmentation by type and application, regional analysis across North America, Europe, Asia-Pacific and Middle East & Africa, and competitive landscape details. For instance, the report includes the fact that in 2023 the global plant extracts market size was estimated at USD 35,800 million, rising toward USD 100,190 million by 2034. Another fact: standardized extracts accounted for approximately 63% of usage in 2023 and new botanical-extract launches incorporating green-extraction technologies increased by 27% in 2023.
Plant Extracts Market Report Coverage
| REPORT COVERAGE | DETAILS | |
|---|---|---|
|
Market Size Value In |
USD 47213.15 Million in 2026 |
|
|
Market Size Value By |
USD 103562.41 Million by 2035 |
|
|
Growth Rate |
CAGR of 9.12% from 2026 - 2035 |
|
|
Forecast Period |
2026 - 2035 |
|
|
Base Year |
2025 |
|
|
Historical Data Available |
Yes |
|
|
Regional Scope |
Global |
|
|
Segments Covered |
By Type :
By Application :
|
|
|
To Understand the Detailed Market Report Scope & Segmentation |
||
Frequently Asked Questions
The global Plant Extracts Market is expected to reach USD 103562.41 Million by 2035.
The Plant Extracts Market is expected to exhibit a CAGR of 9.12% by 2035.
Natural Remedies,Active Ingredients Group,Novanat,Aovca,Bioprex Labs,Gaoke Group,Tsumura&Co,Green-Health,Wagott Bio-Tech,Martin Bauer,Conba Group,Euromed,Sabinsa,Naturex,LIWAH,Organic Herb Inc,JiaHerb,Rainbow,Provital Group,Layn,BGG,Chenguang Biotech,Lgberry,IndenaSPA,Schwabe are top companes of Plant Extracts Market.
In 2025, the Plant Extracts Market value stood at USD 43267.18 Million.
Our Clients
Brief With: